L-Carnitine | Linus Pauling Institute
US$ 29.78
aod9604 fat loss clinical trial The effect of a single daily ip dose of saline, AOD9604, or hGH on body AOD-9604 Safety Profile: What Clinical
Description
The albumin-bound peptide acts as a reservoir, slowly releasing active drug over days
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Subcutaneous Protocol (4 mL = 12.5 mg/mL) Frequency: Inject once or twice daily subcutaneously
Who it's for
Providers must include a clear statement of the patients diagnosis (e.g., primary immunodeficiency disorders [ICD-10 D80-D84], chronic inflammatory demyelinating polyneuropathy [ICD-10 G61.81]) and evidence of medical necessity
